The Scientific Rationale of Combining Inhaled Glucocorticoids and Long Acting Beta 2 Adrenoceptor Agonists

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|8|20|1863-1869

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.8, Iss.20, 2002-09, pp. : 1863-1869

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Acting Beta-Agonists and their Association with Inhaled Corticosteroids in COPD

By  

Current Medicinal Chemistry, Vol. 20, Iss. 12, 2013-06 ,pp. : 1477-1495

Bentham Science Publishers

Access to resources Recommend Favorite

Long-acting 2-adrenoceptor agonists: increased risk of death?

By  

Reactions Weekly, Vol. 1, Iss. 1072, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma: A Pragmatic Trial

By Wilson Edward C.F.  

PharmacoEconomics, Vol. 28, Iss. 7, 2010-07 ,pp. : 597-608

Adis International

Access to resources Recommend Favorite

Effect of short- and long-acting 2 -adrenoceptor agonists on pulmonary 2 -adrenoceptor expression in human lung

By Nishikawa M.   Mak J.C.W.   Barnes P.J.  

European Journal of Pharmacology, Vol. 318, Iss. 1, 1996-12 ,pp. : 123-129

Elsevier

Access to resources Recommend Favorite

Some Pharmacodynamic Aspects on Long-Acting -Adrenoceptor Agonists

By Waldeck B.  

General Pharmacology, Vol. 27, Iss. 4, 1996-06 ,pp. : 575-580

Elsevier

Access to resources Recommend Favorite